Cancer microenvironment and endoplasmic reticulum stress response

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Giampietri, Claudia ^a   Petrungaro, Simonetta ^a   Conti, Silvia ^a   Facchiano, Antonio ^b   Filippini, Antonio ^a   Ziparo, Elio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ACIDOSIS; ANGIOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; HUMAN; HYPOXIA; MELANOMA; NEOPLASM; NONHUMAN; NUTRIENT DEPRIVATION; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE; ANIMAL; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; ENDOPLASMIC RETICULUM STRESS; HUMANS; MALE; MELANOMA; PROSTATIC NEOPLASMS; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE;

EID: 84944474385     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/417281     Document Type: Review

References (124)

1. W. A. Wang, J. Groenendyk, and M. Michalak, "Endoplasmic reticulum stress associated responses in cancer," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1843, no. 10, pp. 2143-2149, 2014.
2. M. Wang and R. J. Kaufman, "The impact of the endoplasmic reticulum protein-folding environment on cancer development," Nature Reviews Cancer, vol. 14, no. 9, pp. 581-597, 2014.
3. R. K. Yadav, S. W. Chae, H. R. Kim, and H. J. Chae, "Endoplas-mic reticulum stress and cancer," Journal of Cancer Prevention, vol. 19, no. 2, pp. 75-88, 2014.
4. J. M. Brown and A. J. Giaccia, "The unique physiology of solid tumors: opportunities (and problems) for cancer therapy," Cancer Research, vol. 58, no. 7, pp. 1408-1416, 1998.
5. B. He, "Viruses, endoplasmic reticulum stress, and interferon responses," Cell Death and Diferentiation, vol. 13, no. 3, pp. 393-403, 2006.
6. F. Martinon, "Targeting endoplasmic reticulum signaling pathways in cancer," Acta Oncologica, vol. 51, no. 7, pp. 822-830, 2012.
7. M. Moenner, O. Pluquet, M. Bouchecareilh, and E. Chevet, "Integrated endoplasmic reticulum stress responses in cancer," Cancer Research, vol. 67, no. 22, pp. 10631-10634, 2007.
8. C. Koumenis, "ER stress, hypoxia tolerance and tumor progression," Current Molecular Medicine, vol. 6, no. 1, pp. 55-69, 2006.
9. A. H. Schonthal, "Targeting endoplasmic reticulum stress for cancer therapy," Frontiers in Bioscience, vol. 4, pp. 412-431, 2012.
10. I. Tabas and D. Ron, "Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress," Nature Cell Biology, vol. 13, no. 3, pp. 184-190, 2011.
11. K. Kohno, K. Normington, J. Sambrook, M.-J. Gething, and K. Mori, "The promoter region of the yeast KAR2 (BiP) gene contains a regulatory domain that responds to the presence of unfolded proteins in the endoplasmic reticulum," Molecular and Cellular Biology, vol. 13, no. 2, pp. 877-890, 1993.
12. C. E. Shamu, J. S. Cox, and P. Walter, "The unfolded-protein-response pathway in yeast," Trends in Cell Biology, vol. 4, no. 2, pp. 56-60, 1994.
13. H. P. Harding, Y. Zhang, A. Bertolotti, H. Zeng, and D. Ron, "Perk is essential for translational regulation and cell survival during the unfolded protein response," Molecular Cell, vol. 5, no. 5, pp. 897-904, 2000.
14. J. S. Cox, C. E. Shamu, and P. Walter, "Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase," Cell, vol. 73, no. 6, pp. 1197-1206, 1993.
15. K. Haze, H. Yoshida, H. Yanagi, T. Yura, and K. Mori, "Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress," Molecular Biology of the Cell, vol. 10, no. 11, pp. 3787-3799, 1999.
16. A. Bertolotti, Y Zhang, L. M. Hendershot, H. P. Harding, and D. Ron, "Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response," Nature Cell Biology, vol. 2, no. 6, pp. 326-332, 2000.
17. D. Ron and P. Walter, "Signal integration in the endoplasmic reticulum unfolded protein response," Nature Reviews Molecular Cell Biology, vol. 8, no. 7, pp. 519-529, 2007
18. R. V. Rao, A. Peel, A. Logvinova et al., "Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78," FEBS Letters, vol. 514, no. 2-3, pp. 122-128, 2002.
19. R. J. Kaufman and J. D. Malhotra, "Calcium trafcking integrates endoplasmic reticulum function with mitochondrial bioenergetics," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1843, no. 10, pp. 2233-2239, 2014.
20. J. E. Vance, "Phospholipid synthesis in a membrane fraction associated with mitochondria," The Journal of Biological Chemistry, vol. 265, no. 13, pp. 7248-7256, 1990.
21. E. S. Marini, C. Giampietri, S. Petrungaro et al., "The endogenous caspase-8 inhibitor c-FLIP " regulates ER morphology and crosstalk with mitochondria, Cell Death & Diferentiation, 2014.
22. A. R. van Vliet, T. Verfaillie, and P. Agostinis, "New functions of mitochondria associated membranes in cellular signaling," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1843, no. 10, pp. 2253-2262, 2014.
23. T. W. Fawcett, J. L. Martindale, K. Z. Guyton, T. Hai, and N. J. Holbrook, "Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response," Biochemical Journal, vol. 339, no. 1, pp. 135-141, 1999.
24. Y Ma and L. M. Hendershot, "The unfolding tale of the unfolded protein response," Cell, vol. 107, no. 7, pp. 827-830, 2001.
25. M. Calfon, H. Zeng, F. Urano et al., "IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA," Nature, vol. 415, no. 6867, pp. 92-96, 2002.
26. H. Yoshida, T. Matsui, A. Yamamoto, T. Okada, and K. Mori, "XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor," Cell, vol. 107, no. 7, pp. 881-891, 2001.
27. H. Nishitoh, A. Matsuzawa, K. Tobiume et al., "ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats," Genes and Development, vol. 16, no. 11, pp. 1345-1355, 2002.
28. 2+ homeostasis and apoptosis," EMBO Journal, vol. 23, no. 5, pp. 1207-1216, 2004.
29. E. S. Papadakis, K. G. Finegan, X. Wang et al., "The regulation of Bax by c-Jun N-terminal protein kinase (JNK) is a prerequisite to the mitochondrial-induced apoptotic pathway," FEBS Letters, vol. 580, no. 5, pp. 1320-1326, 2006.
30. G. V. Putcha, S. Le, S. Frank et al., "JNK-mediated BIM phos-phorylation potentiates BAX-dependent apoptosis," Neuron, vol. 38, no. 6, pp. 899-914, 2003.
31. M. Maurel, E. Chevet, J. Tavernier, and S. Gerlo, "Getting RIDD of RNA: IRE1 in cell fate regulation," Trends in Biochemical Sciences, vol. 39, no. 5, pp. 245-254, 2014.
32. J. Dudek, J. Benedix, S. Cappel et al., "Functions and pathologies of BiP and its interaction partners," Cellular and Molecular Life Sciences, vol. 66, no. 9, pp. 1556-1569, 2009.
33. Y. Fu, J. Li, and A. S. Lee, "GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis," Cancer Research, vol. 67, no. 8, pp. 3734-3740, 2007.
34. R. K. Reddy, C. Mao, P. Baumeister, R. C. Austin, R. J. Kaufman, and A. S. Lee, "Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation," The Journal of Biological Chemistry, vol. 278, no. 23, pp. 20915-20924, 2003.
35. C. C. Jiang, L. H. Chen, S. Gillespie et al., "Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis," Cancer Research, vol. 67, no. 20, pp. 9750-9761, 2007.
36. E. Lee, P. Nichols, D. Spicer, S. Groshen, M. C. Yu, and A. S. Lee, "GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer," Cancer Research, vol. 66, no. 16, pp. 7849-7853, 2006.
37. M. Firczuk, M. Gabrysiak, J. Barankiewicz et al., "GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photody-namic therapy," Cell Death and Disease, vol. 4, no. 7, article e741, 2013.
38. J. Kang, G. Zhao, T. Lin et al., "A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells," Cancer Letters, vol. 339, no. 2, pp. 247-259, 2013.
39. L. S. Hart, J. T. Cunningham, T. Datta et al., "ER stressmediated autophagy promotes Myc-dependent transformation and tumor growth," Journal of Clinical Investigation, vol. 122, no. 12, pp. 4621-4634, 2012.
40. E. Bobrovnikova-Marjon, C. Grigoriadou, D. Pytel et al., "PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage," Oncogene, vol. 29, no. 27, pp. 3881-3895, 2010.
41. J. D. Blais, C. L. Addison, R. Edge et al., "Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress," Molecular and Cellular Biology, vol. 26, no. 24, pp. 9517-9532, 2006.
42. J. M. Axten, J. R. Medina, Y. Feng et al., "Discovery of 7-methyl-5-(1-[3-(trifuoromethyl)phenyl]acetyl-2, 3-dihydro-1H-indol-5-yl)-7H-p yrrolo[2, 3-d]pyrimidin-4-amine (GSK2606414), a potent and selective frst-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)," Journal of Medicinal Chemistry, vol. 55, no. 16, pp. 7193-7207, 2012.
43. T. Fujimoto, M. Onda, H. Nagai, T. Nagahata, K. Ogawa, and M. Emi, "Upregulation and overexpression of human X-box binding protein 1 (hXBP-1) gene in primary breast cancers," Breast Cancer, vol. 10, no. 4, pp. 301-306, 2003.
44. S. Y. Hong and T. Hagen, "Multiple myeloma Leu167Ile (c.499C>A) mutation prevents XBP1 mRNA splicing," British Journal of Haematology, vol. 161, no. 6, pp. 898-901, 2013.
45. M. Shuda, N. Kondoh, N. Imazeki et al., "Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcino-genesis," Journal of Hepatology, vol. 38, no. 5, pp. 605-614, 2003.
46. D. R. Carrasco, K. Sukhdeo, M. Protopopova et al., "The diferentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis," Cancer Cell, vol. 11, no. 4, pp. 349-360, 2007.
47. N. Mimura, M. Fulciniti, G. Gorgun et al., "Blockade of XBP1 splicing by inhibition of IRE1γis a promising therapeutic option in multiple myeloma," Blood, vol. 119, no. 24, pp. 5772-5781, 2012.
48. J. A. Torpe and S. R. Schwarze, "IRE1alpha controls cyclin A1 expression and promotes cell proliferation through XBP-1," Cell Stress and Chaperones, vol. 15, no. 5, pp. 497-508, 2010.
49. I. Papandreou, N. C. Denko, M. Olson et al., "Identifcation of an Ire1alpha endonuclease specifc inhibitor with cytotoxic activity against human multiple myeloma," Blood, vol. 117, no. 4, pp. 1311-1314, 2011.
50. J. Ye, M. Kumanova, L. S. Hart et al., "The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation," The EMBO Journal, vol. 29, no. 12, pp. 2082-2096, 2010.
51. C.-F. Fan, Y. Miao, X.-Y. Lin, D. Zhang, and E.-H. Wang, "Expression of a phosphorylated form of ATF4 in lung and non-small cell lung cancer tissues," Tumor Biology, vol. 35, no. 1, pp. 765-771, 2014.
52. M. Horiguchi, S. Koyanagi, A. Okamoto, S. O. Suzuki, N. Matsunaga, and S. Ohdo, "Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors," Cancer Research, vol. 72, no. 2, pp. 395-401, 2012.
53. B. Luo and A. S. Lee, "The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumori-genesis and anticancer therapies," Oncogene, vol. 32, no. 7, pp. 805-818, 2013.
54. C. Hetz, E. Chevet, and H. P. Harding, "Targeting the unfolded protein response in disease," Nature Reviews Drug Discovery, vol. 12, no. 9, pp. 703-719, 2013.
55. M. Guzmán, "Cannabinoids: potential anticancer agents," Nature Reviews Cancer, vol. 3, no. 10, pp. 745-755, 2003.
56. G. Velasco, T. Verfaillie, M. Salazar, and P. Agostinis, "Linking ER stress to autophagy: potential implications for cancer therapy," International Journal of Cell Biology, vol. 2010, Article ID 930509, 19 pages, 2010.
57. J. L. Brodsky, "Cleaning Up: ER-associated degradation to the rescue," Cell, vol. 151, no. 6, pp. 1163-1167, 2012.
58. R. Y. Hampton, R. G. Gardner, and J. Rine, "Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticu-lum membrane protein," Molecular Biology of the Cell, vol. 7, no. 12, pp. 2029-2044, 1996.
59. M. Knop, A. Finger, T. Braun, K. Hellmuth, and D. H. Wolf, "Der1, a novel protein specifcally required for endoplasmic reticulum degradation in yeast," The EMBO Journal, vol. 15, no. 4, pp. 753-763, 1996.
60. R. Friedlander, E. Jarosch, J. Urban, C. Volkwein, and T. Sommer, "A regulatory link between ER-associated protein degradation and the unfolded-protein response," Nature Cell Biology, vol. 2, no. 7, pp. 379-384, 2000.
61. S. S. Vembar and J. L. Brodsky, "One step at a time: endoplasmic reticulum-associated degradation," Nature Reviews Molecular Cell Biology, vol. 9, no. 12, pp. 944-957, 2008.
62. B. Mueller, E. J. Klemm, E. Spooner, J. H. Claessen, and H. L. Ploegh, "SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 34, pp. 12325-12330, 2008.
63. H. Kim, A. Bhattacharya, and L. Qi, "Endoplasmic reticulum quality control in cancer: friend or foe," Seminars in Cancer Biology, 2015.
64. C. Denoyelle, G. Abou-Rjaily, V. Bezrookove et al., "Anti-oncogenic role of the endoplasmic reticulum diferentially activated by mutations in the MAPK pathway," Nature Cell Biology, vol. 8, no. 10, pp. 1053-1063, 2006.
65. R. Ghosh, L. Wang, E. Wang et al., "Allosteric inhibition of the IRE1alpha RNase preserves cell viability and function during endoplasmic reticulum stress," Cell, vol. 158, no. 3, pp. 534-548, 2014.
66. S. Ranatunga, C.-H. A. Tang, C. W. Kang et al., "Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity," Journal of Medicinal Chemistry, vol. 57, no. 10, pp. 4289-4301, 2014.
67. A. Bruchmann, C. Roller, T. V. Walther et al., "Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis," BMC Cancer, vol. 13, article 96, 2013.
68. K. H. Tay, Q. Luan, A. Crof et al., "Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress," Cellular Signalling, vol. 26, no. 2, pp. 287-294, 2014.
69. D. Cojocari, R. N. Vellanki, B. Sit, D. Uehling, M. Koritzinsky, and B. G. Wouters, "New small molecule inhibitors of UPR activation demonstrate that PERK, but not IRE1alpha signaling is essential for promoting adaptation and survival to hypoxia," Radiotherapy and Oncology, vol. 108, no. 3, pp. 541-547, 2013.
70. D. R. Fels and C. Koumenis, "The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth," Cancer Biology and Terapy, vol. 5, no. 7, pp. 723-728, 2006.
71. C. Koumenis, C. Naczki, M. Koritzinsky et al., "Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2γ," Molecular and Cellular Biology, vol. 22, no. 21, pp. 7405-7416, 2002.
72. L. Romero-Ramirez, H. Cao, D. Nelson et al., "XBP1 is essential for survival under hypoxic conditions and is required for tumor growth," Cancer Research, vol. 64, no. 17, pp. 5943-5947, 2004.
73. J. Brocato, Y. Chervona, and M. Costa, "Molecular responses to hypoxia-inducible factor 1γ and beyond," Molecular Pharmacology, vol. 85, no. 5, pp. 651-657, 2014.
74. Y.-P. Vandewynckel, D. Laukens, A. Geerts et al., "The paradox of the unfolded protein response in cancer," Anticancer Research, vol. 33, no. 11, pp. 4683-4694, 2013.
75. B. Gess, K. H. Hofauer, R. H. Wenger, C. Lohaus, H. E. Meyer, and A. Kurtz, "The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lγ," European Journal of Biochemistry, vol. 270, no. 10, pp. 2228-2235, 2003.
76. A. Glasauer and N. S. Chandel, "Targeting antioxidants for cancer therapy," Biochemical Pharmacology, vol. 92, no. 1, pp. 90-101, 2014.
77. T.-I. Peng and M.-J. Jou, "Oxidative stress caused by mitochon-drial calcium overload," Annals of the New York Academy of Sciences, vol. 1201, pp. 183-188, 2010.
78. J. H. Yu and H. Kim, "Oxidative stress and cytokines in the pathogenesis of pancreatic cancer," Journal of Cancer Prevention, vol. 19, no. 2, pp. 97-102, 2014.
79. R. Eferl and E. F. Wagner, "AP-1: a double-edged sword in tumorigenesis," Nature Reviews Cancer, vol. 3, no. 11, pp. 859-868, 2003.
80. K. Zhang, X. Shen, J. Wu et al., "Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic infammatory response," Cell, vol. 124, no. 3, pp. 587-599, 2006.
81. A. B. Tam, E. L. Mercado, A. Hofmann, and M. Niwa, "ER stress activates NF-γB by integrating functions of basal IKK activity, IRE1 and PERK," PLoS ONE, vol. 7, no. 10, Article ID e45078, 2012.
82. Y. Zhang, H. Wang, J. Li et al., "Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation," Journal of Neuroscience, vol. 24, no. 47, pp. 10616-10627, 2004.
83. S. Nakajima, N. Hiramatsu, K. Hayakawa et al., "Selective abrogation of BiP/GRP78 blunts activation of NF-γB through the ATF6 branch of the UPR: involvement of C/EBPγ and mTOR-dependent dephosphorylation of Akt," Molecular and Cellular Biology, vol. 31, no. 8, pp. 1710-1718, 2011.
84. H. Yamazaki, N. Hiramatsu, K. Hayakawa et al., "Activation of the Akt-NF-γB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response," The Journal of Immunology, vol. 183, no. 2, pp. 1480-1487, 2009.
85. P. Hu, Z. Han, A. D. Couvillon, R. J. Kaufman, and J. H. Exton, "Autocrine tumor necrosis factor γ links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1γ-mediated NF-γB activation and down-regulation of TRAF2 expression," Molecular and Cellular Biology, vol. 26, no. 8, pp. 3071-3084, 2006.
86. J. Oh, A. E. Riek, S. Weng et al., "Endoplasmic reticulum stress controls M2 macrophage diferentiation and foam cell formation," The Journal of Biological Chemistry, vol. 287, no. 15, pp. 11629-11641, 2012.
87. J. C. Goodall, C. Wu, Y. Zhang et al., "Endoplasmic reticu-lum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 41, pp. 17698-17703, 2010.
88. L. Wang, T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu, "IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway," Journal of Experimental Medicine, vol. 206, no. 7, pp. 1457-1464, 2009.
89. H. R. Park, A. Tomida, S. Sato et al., "Efect on tumor cells of blocking survival response to glucose deprivation," Journal of the National Cancer Institute, vol. 96, no. 17, pp. 1300-1310, 2004.
90. C. E. Moore, O. Omikorede, E. Gomez, G. B. Willars, and T. P. Herbert, "PERK activation at low glucose concentration is mediated by SERCA pump inhibition and confers preemptive cytoprotection to pancreatic γ-cells," Molecular Endocrinology, vol. 25, no. 2, pp. 315-326, 2011.
91. R. P. C. Shiu, J. Pouyssegur, and I. Pastan, "Glucose depletion accounts for the induction of two transformation-sensitive membrane proteins in Rous sarcoma virus-transformed chick embryo fbroblasts," Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 9, pp. 3840-3844, 1977.
92. M. T. Spiotto, A. Banh, I. Papandreou et al., "Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth," Cancer Research, vol. 70, no. 1, pp. 78-88, 2010.
93. T. Amann, U. Maegdefrau, A. Hartmann et al., "GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis," The American Journal of Pathology, vol. 174, no. 4, pp. 1544-1552, 2009.
94. C. Ryder, K. McColls, F. Zhongs, and C. W. Distelhorst, "Acidosis promotes Bcl-2 family-mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor GPR65 signaling to MEK/ERK," The Journal of Biological Chemistry, vol. 287, no. 33, pp. 27863-27875, 2012.
95. C. B. Ryder, K. McColl, and C. W. Distelhorst, "Acidosis blocks CCAAT/enhancer-binding protein homologous protein (CHOP)-and c-Jun-mediated induction of p53-upregulated mediator of apoptosis (PUMA) during amino acid starvation," Biochemical and Biophysical Research Communications, vol. 430, no. 4, pp. 1283-1288, 2013.
96. S. Ishimura, T. Mita, Y. Watanabe et al., "Reduction of endoplas-mic reticulum stress inhibits neointima formation afer vascular injury," Scientifc Reports, vol. 4, article 6943, 2014.
97. L. W. Reneker, H. Chen, and P. A. Overbeek, "Activation of unfolded protein response in transgenic mouse lenses," Investigative Ophthalmology and Visual Science, vol. 52, no. 5, pp. 2100-2108, 2011.
98. H. Dihazi, G. H. Dihazi, A. Bibi et al., "Secretion of ERP57 is important for extracellular matrix accumulation and progression of renal fbrosis, and is an early sign of disease onset," Journal of Cell Science, vol. 126, no. 16, pp. 3649-3663, 2013.
99. F. de Marchis, D. Ribatti, C. Giampietri et al., "Platelet-derived growth factor inhibits basic fbroblast growth factor angiogenic properties in vitro and in vivo through its γ receptor," Blood, vol. 99, no. 6, pp. 2045-2053, 2002.
100. D. Faraone, M. S. Aguzzi, G. Toietta et al., "Platelet-derived growth factor-receptor γ strongly inhibits melanoma growth in vitro and in vivo," Neoplasia, vol. 11, no. 8, pp. 732-742, 2009.
101. C. Cenciarelli, H. E. Marei, M. Zonfrillo et al., "PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment," Molecular Cancer, vol. 13, no. 1, article 247, 2014.
102. N. A. Luo, Y. Q. Qu, G. D. Yang et al., "Post-transcriptional up-regulation of PDGF-C by HuR in advanced and stressed breast cancer," International Journal of Molecular Sciences, vol. 15, no. 11, pp. 20306-20320, 2014.
103. O. M. Tudoran, O. Soritau, L. Balacescu et al., "PDGF beta targeting in cervical cancer cells suggest a fne-tuning of compensatory signalling pathways to sustain tumourigenic stimulation," Journal of Cellular and Molecular Medicine, vol. 19, no. 2, pp. 371-382, 2015.
104. B. Li, Z. Pi, L. Liu et al., "FGF-2 prevents cancer cells from ER stress-mediated apoptosis via enhancing proteasome-mediated Nck degradation," Biochemical Journal, vol. 452, no. 1, pp. 139-145, 2013.
105. Y. Wang, G. N. Alam, Y. Ning et al., "The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway," Cancer Research, vol. 72, no. 20, pp. 5396-5406, 2012.
106. E. Karali, S. Bellou, D. Stellas, A. Klinakis, C. Murphy, and T. Fotsis, "VEGF Signals through ATF6 and PERK to Promote Endothelial Cell Survival and Angiogenesis in the Absence of ER Stress," Molecular Cell, vol. 54, no. 4, pp. 559-572, 2014.
107. L. Liu, X. Qi, Z. Chen et al., "Targeting the IRE1γ/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization," The American Journal of Pathology, vol. 182, no. 4, pp. 1412-1424, 2013.
108. R. Ghosh, K. L. Lipson, K. E. Sargent et al., "Transcriptional regulation of VEGF-A by the unfolded protein response pathway," PLoS ONE, vol. 5, no. 3, Article ID e9575, 2010.
109. M. Maurel, E. P. McGrath, K. Mnich, S. Healy, E. Chevet, and A. Samali, "Controlling the unfolded protein response-mediated life and death decisions in cancer," Seminars in Cancer Biology, 2015.
110. E. Rico-Bautista, W. Zhu, S. Kitada et al., "Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via unfolded protein response signaling," Oncotarget, vol. 4, no. 8, pp. 1212-1229, 2013.
111. S. Qiao, C. M. Cabello, S. D. Lamore, J. L. Lesson, and G. T. Won-drak, "D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis," Apoptosis, vol. 17, no. 10, pp. 1079-1094, 2012.
112. L. Papa, G. Manfredi, and D. Germain, "SOD1, an unexpected novel target for cancer therapy," Genes Cancer, vol. 5, no. 1-2, pp. 15-21, 2014.
113. S. G. Kelsen, "Respiratory epithelial cell responses to cigarette smoke: the unfolded protein response," Pulmonary Pharmacology and Terapeutics, vol. 25, no. 6, pp. 447-452, 2012.
114. F. Rizzi, V. Naponelli, A. Silva et al., "Polyphenon E, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis," Carcinogenesis, vol. 35, no. 4, pp. 828-839, 2014.
115. S. Martin, D. S. Hill, J. C. Paton et al., "Targeting GRP78 to enhance melanoma cell death," Pigment Cell and Melanoma Research, vol. 23, no. 5, pp. 675-682, 2010.
116. S. Martin, P. E. Lovat, and C. P. Redfern, "Cell-type variation in stress responses as a consequence of manipulating GRP78 expression in neuroectodermal cells," Journal of Cellular Biochemistry, vol. 116, no. 3, pp. 438-449, 2015.
117. J. H. Song and A. S. Kraf, "Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737," Cancer Research, vol. 72, no. 1, pp. 294-303, 2012.
118. A. L. Davis, S. Qiao, J. L. Lesson et al., "The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells," Journal of Biological Chemistry, vol. 290, no. 3, pp. 1623-1638, 2015.
119. R. K. Yadav, S. W. Chae, H. R. Kim, and H. J. Chae, "Endoplas-mic reticulum stress and cancer," Journal of Cancer Prevention, vol. 19, no. 2, pp. 75-88, 2014.
120. A. Tomida and T. Tsuruo, "Drug resistance mediated by cellular stress response to the microenvironment of solid tumors," AntiCancer Drug Design, vol. 14, no. 2, pp. 169-177, 1999.
121. W. Chien, L. W. Ding, Q. Y. Sun et al., "Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells," Oncotarget, vol. 5, no. 13, pp. 4881-4894, 2014.
122. X. Li, K. Zhang, andZ. Li, "Unfolded protein response in cancer: the Physician's perspective," Journal of Hematology & Oncology, vol. 4, article 8, 2011.
123. D. J. Mahoney, C. Lefebvre, K. Allan et al., "Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death," Cancer Cell, vol. 20, no. 4, pp. 443-456, 2011.
124. B. C. S. Cross, C. McKibbin, A. C. Callan et al., "Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplas-mic reticulum," Journal of Cell Science, vol. 122, part 23, pp. 4393-4400, 2009.